Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • Canadian Institutes of Health Research (MOP-130566)

This publication has 26 references indexed in Scilit: